STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] CHEMED CORP SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

CHE has a Form 144 notice indicating a planned sale of 2,000 common shares. The shares are to be sold through Raymond James & Associates on or about 11/24/2025 on the NYSE, with an aggregate market value of $876,000. Shares outstanding were 14,110,000; this is a baseline figure, not the amount being sold.

The seller acquired the shares through stock awards from the issuer in 2016. The filing also lists prior sales over the past three months by Kevin J McNamara, including 1,000 common shares for gross proceeds of $460,647 and 2,000 common shares for $922,794, both on 09/26/2025. The signer represents they are not aware of undisclosed material adverse information about the issuer.

Positive
  • None.
Negative
  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CHE Form 144 filing disclose?

The Form 144 for CHE discloses a planned sale of 2,000 shares of the issuer's common stock, to be executed through Raymond James & Associates on or about 11/24/2025 on the NYSE, with an aggregate market value of $876,000.

How many CHE shares are planned to be sold under this Form 144?

The notice covers 2,000 common shares of CHE, with an indicated aggregate market value of $876,000 at the time of the filing.

How many CHE shares were outstanding in this Form 144 excerpt?

The Form 144 excerpt reports that the number of CHE common shares outstanding was 14,110,000, providing context for the planned sale amount.

Who is the selling security holder in the CHE Form 144 and how were the shares acquired?

The selling holder identified is Kevin J McNamara. The shares to be sold were acquired through stock awards from the issuer in 2016, with multiple award dates listed.

What prior CHE share sales are disclosed for the last 3 months?

The filing lists prior sales during the past three months by Kevin J McNamara: 1,000 common shares sold on 09/26/2025 for gross proceeds of $460,647 and 2,000 common shares sold the same day for $922,794.

What representation does the seller make in the CHE Form 144?

By signing the notice, the seller represents that they do not know of any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, and this representation also applies as of any stated Rule 10b5-1 plan adoption date.

Chemed Corp

NYSE:CHE

CHE Rankings

CHE Latest News

CHE Latest SEC Filings

CHE Stock Data

6.06B
13.88M
1.98%
97.98%
2.82%
Medical Care Facilities
Services-home Health Care Services
Link
United States
CINCINNATI